Methicillin-Resistant Staphylococcus Aureus Infection

MRSA infection, methicillin-resistant Staphylococcus aureus is a staphylococcal infection that is particularly resistant to traditional antibiotics, and treatment and relaxation are very difficult. In general, infections are spreading to hospitals and other medical institutions, for example, weak immune people, infants and the elderly, homeless people, prison people, crowded busy unsanitary areas. . Although MRSA is diagnosed by examining body fluids in the laboratory, these tests are often used to confirm that medical experts suspect disease based on patient symptoms.

MRSA stands for methicillin-resistant Staphylococcus aureus. It causes staphylococcal infections (pronounced "employee infections") and is resistant to some common antibiotics. There are two kinds of infectious diseases. Hospital-related MRSA occurs to people in medical facilities. Regional society-related MRSA occurs in people touching the skin with other people, such as football and athletes participating in wrestling.

Resistance to first-line drugs for the treatment of infections caused by Staphylococcus aureus is common, which is a common cause of serious infections in health care facilities and communities. Patients with MRSA (methicillin-resistant Staphylococcus aureus) are more likely to die 64% than non-resistant people. The World Health Organization (WHO) estimates that there are about 480,000 new MDR-TBs in 2014. It is tuberculosis that is resistant to the two most effective anti-tuberculosis drugs. Only about a quarter (123 000 cases) were discovered and reported. Multidrug-resistant tuberculosis requires a longer treatment period than non-drug resistant tuberculosis, its effect is worse. Worldwide, only half of MDR-TB patients successfully treated in 2014

AMR is often associated with hospital-based infections such as MRSA (methicillin-resistant Staphylococcus aureus), but about 29% of deaths due to today's antibiotic infection are due to drug-resistant tuberculosis. Indeed, the harsh predictions of "late antibiotics" are reality for many countries and patients who are experiencing multidrug resistance (MDR-) and extensive drug resistance (XDR -) and economic loss . MDR-TB, TB multidrug-resistant tuberculosis, is defined as the resistance to isoniazid and rifampicin, the two most commonly used drugs in the currently used four drug (or first-line drug) regimens It has been. This is the result of the treatment of interrupted, unstable or inappropriate tuberculosis, the spread of tuberculosis has compromised the efforts to control the global tuberculosis outbreak. Drug-resistant tuberculosis occurs when insufficient management of complicated and decades-old tuberculosis treatment programs over the long term, or when drugs are discontinued before TB patients are completely eradicated.